August 6, 2025 · Form 4 insider transaction
Treco Douglas A bought 20,000 shares of CRISPR Therapeutics AG at $57.03 per share, a transaction worth $1.14M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Open market purchase of shares in accordance with Issuer's trading policies.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.92 to $57.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.